Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Mankind Pharma Ltd.
Swot
Mankind Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Mankind Pharma Ltd. has 11 Strengths, 5 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(11)
Weakness
(5)
Opportunity
(0)
Threats
(2)
Others
(6)
Consistent Highest Return Stocks over Five Years
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
PE higher than Industry PE
PEG greater than Industry PEG
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Companies with high market cap, lower public shareholding
MFs decreased their shareholding last quarter
High Piotroski Score - Companies with strong financials
Bullish or Bearish Candlestick Strength - Indices
Expensive Performers (DVM)
Bullish Engulfing Pattern (Bullish Reversal)
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
